Summary
Approximately 10 percent of individuals with primary myelofibrosis (PMF) and essential thrombocythemia (ET) are triple negative, meaning they are negative for the driver mutations JAK2, MPL, or CALR.
1
This term is no longer restricted to breast cancer.
1
According to
Abstract. Introduction: Triple negative primary myelofibrosis (TN- PMF ) and myelodysplastic syndromes with fibrosis (F-MDS) are rare entities, often difficult to distinguish each other. Currently, no specific molecular markers allowing a precise…
Triple Negative Myelofibrosis and Myelodysplastic Syndrome with ...
ashpublications.org
Primary myelofibrosis ( PMF ): The common symptoms include fatigue, night sweats, low-grade fever, early satiety, weight loss, abdominal fullness or discomfort, dysuria, hematuria, gastrointestinal (GI) bleeding, arthralgia, and bony pain. PMF …
Myeloproliferative Neoplasms - StatPearls - NCBI Bookshelf
nih.gov
The most well-known MPN is chronic myeloid leukemia, (CML), characterized by the classic BCR-ABL1 rearrangement. There are BCR-ABL1 - negative MPNs as well (polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis…
Going Beyond Driver Mutations in Myeloproliferative Neoplasms
cap.org